Clinical Trial Update: Study of Propranolol as Anti-Adhesive Therapy in Sickle Cell Disease (SCD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated propranolol as an anti-adhesive therapy for sickle cell disease and has completed with results posted in January 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Laura M. De Castro, MD | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED | Results posted: 2015-01-22